Mirjam Langeveld ,

Consultant inherited metabolic disorders and principal investigator, Department of Endocrinology and Metabolism, Academic Medical Center (AMC), Amsterdam, the Netherlands-

ACCOMPLISHMENTS I lead my research team performing clinical studies on lysosomal storage diseases, fatty acid oxidation disorders and complex diagnostics of IEMs. The team includes PhDs students (currently 4), post-docs, (data) managers, research nurses and patient care coordinators.

Currently I’m the PI for two phase 3 study for new therapies for Fabry disease (new form ERT and substrate reduction therapy). I have set up several international collaborative projects among which the Fabry genotype-phenotype database. I’ve published 59 original papers and peer-reviewed for international journals such as PLOS ONE, Journal of Inherited Metabolic Disorders and Orphanet Journal of Rare Diseases. Since July 2020 I’m the head of the Internisten voor Erfelijke Stofwisselingsziekten (INVEST) working group. Since 2016 I am secretary of the adult committee of the SSIEM.